Frazier Life Sciences Management’s Autolus Therapeutics AUTL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.14M	Sell	4,447,910 -175,414	-4%	-$266K	0.16%	36
2025 Q4	$9.2M	Hold	4,623,324	–	–	0.25%	36
2025 Q3	$7.54M	Hold	4,623,324	–	–	0.23%	43
2025 Q2	$10.5M	Hold	4,623,324	–	–	0.42%	39
2025 Q1	$7.17M	Hold	4,623,324	–	–	0.33%	37
2024 Q4	$10.9M	Hold	4,623,324	–	–	0.45%	35
2024 Q3	$16.8M	Hold	4,623,324	–	–	0.67%	32
2024 Q2	$16.1M	Hold	4,623,324	–	–	0.75%	29
2024 Q1	$29.5M	Buy	4,623,324 +876,467	+23%	+$5.47M	1.24%	25
2023 Q4	$24.1M	Hold	3,746,857	–	–	1.29%	21
2023 Q3	$8.73M	Hold	3,746,857	–	–	0.58%	31
2023 Q2	$8.92M	Hold	3,746,857	–	–	0.53%	34
2023 Q1	$6.89M	Hold	3,746,857	–	–	0.5%	37
2022 Q4	$7.12M	Hold	3,746,857	–	–	0.44%	35
2022 Q3	$8.02M	Hold	3,746,857	–	–	0.62%	34
2022 Q2	$10.6M	Hold	3,746,857	–	–	1%	26
2022 Q1	$15.6M	Buy	+3,746,857	New	+$15.8M	1.33%	24